Learn more about whether Catalyst Pharmaceuticals, Inc. or CRISPR Therapeutics AG is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

The human genome encodes potentially thousands of tiny proteins that were previously overlooked. The search is on to find out ...

Associate Professor Qing Zhong shared insights on AI breakthroughs in proteomics and multiomics, challenges in data sharing ...

A research group at Umeå University has developed new advanced light-controlled tools that enable precise control of proteins in real time in living cells. This research opens doors to new methods for ...

This new tool, known as minimal, versatile genetic perturbation technology (mvGPT), combines the powers of gene editing, ...

"This type of gene editing should also allow for the treatment of diseases whose origin is not genetic or whose origin cannot ...

In two new papers, researchers from The Jackson Laboratory (JAX) report the successful use of two approaches -- gene therapy ...

Scientists studying an aggressive cancer that affects thousands of dogs annually have uncovered a genetic signature that ...

the authors addressed this issue by adding polyaspartate tags to the termini of the Cas protein, enabling effective genome manipulation in Streptomyces. A comprehensive analysis of Cas9-induced ...

The stock of Vertex Pharmaceuticals Incorporated VRTX has declined almost 13% in the past six months. A key reason for the stock price decline was unimpressive data from a phase II study on its key ...

Symptoms of Huntington's disease appear late in life. Research reveals how DNA repeats grow toxic over time, explaining the ...

You don’t need to give up steaks entirely. But mounting evidence shows that a diet that incorporates more plant-based protein has a surprisingly large number of benefits for your health.